ArticleTheranostics2020

EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.

Huilong Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.